scholarly article | Q13442814 |
P2093 | author name string | Solymoss S | |
Flegel KM | |||
Kahn SR | |||
P2860 | cites work | Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Q29614200 |
Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease | Q33613823 | ||
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment | Q36820491 | ||
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q39522420 | ||
Prospective study of endogenous tissue plasminogen activator and risk of stroke | Q41036094 | ||
Endogenous tissue-type plasminogen activator and risk of myocardial infarction | Q41079493 | ||
Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation | Q67269960 | ||
Risk of stroke in non-rheumatic atrial fibrillation | Q69894816 | ||
Relationship between age and plasma t-PA, PA-inhibitor, and PA activity | Q70357338 | ||
Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation | Q70543019 | ||
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study | Q72235431 | ||
Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up | Q72560559 | ||
Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke | Q72773126 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Atrial Fibrillation | Q815819 |
plasminogen | Q107129060 | ||
P304 | page(s) | 685-689 | |
P577 | publication date | 1997-09-01 | |
P1433 | published in | Canadian Medical Association Journal | Q5030320 |
P1476 | title | Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation | |
P478 | volume | 157 |
Q37464600 | Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage |
Q33872912 | Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation |
Q50280905 | Severe Blood-Brain Barrier Disruption in Cardioembolic Stroke. |
Search more.